Colin Lightfoot

Colin Lightfoot

B.Sc. Biomedical Science, M.Sc. Infection and Immunity

Colin graduated from the University of Chester with a B.Sc. in Biomedical Science in 2020. Since completing his undergraduate degree, he worked for NHS England as an Associate Practitioner, responsible for testing inpatients for COVID-19 on admission.

See more

Recently Colin was a Study Assistant for Perfectus Biomed, where he grew cell lines and viruses for the testing of mainly commercial cleaning products. He recently completed an M.Sc. in Infection and Immunity at The University of Chester, where his main research focus was antibiotic resistance and the possibility of combatting this with bacteriophage therapy.

See less

Articles from Colin

Canadian study estimates incidence rate of reinfection in healthcare workers

Canadian study estimates incidence rate of reinfection in healthcare workers

Comparison of SARS-CoV-2 test performance by sample type and modality in close contacts of SARS-CoV-2 cases

Comparison of SARS-CoV-2 test performance by sample type and modality in close contacts of SARS-CoV-2 cases

Measuring T cell responses to SARS-CoV-2 vaccination and infection in healthcare workers with two different assays

Measuring T cell responses to SARS-CoV-2 vaccination and infection in healthcare workers with two different assays

Effectiveness of COVID-19 vaccination 9 months post-vaccination for the population of Sweden

Effectiveness of COVID-19 vaccination 9 months post-vaccination for the population of Sweden

Study finds strong evidence of extensive SARS-CoV-2 infection of white-tailed deer

Study finds strong evidence of extensive SARS-CoV-2 infection of white-tailed deer

Swedish study shows fully vaccinated are protected against severe COVID-19

Swedish study shows fully vaccinated are protected against severe COVID-19

SARS-CoV-2 entry at the cell surface facilitated by trypsin

SARS-CoV-2 entry at the cell surface facilitated by trypsin

Study finds that high-dose convalescent plasma does not improve outcomes for severe COVID-19

Study finds that high-dose convalescent plasma does not improve outcomes for severe COVID-19

Research shows rapid antigen tests can detect SARS-CoV-2 variants, including Omicron

Research shows rapid antigen tests can detect SARS-CoV-2 variants, including Omicron

Reduced neutralization against Omicron variant in fully immunized adolescents with BNT162b2 vaccine

Reduced neutralization against Omicron variant in fully immunized adolescents with BNT162b2 vaccine

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.